Compare AbCellera Biologics Inc (ABCL) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Newmont Corporation — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while Newmont Corporation trades at $119.09 (market cap $123.50B). The key difference: Newmont Corporation is far larger — about 41.3× AbCellera Biologics Inc's market cap, and Newmont Corporation pays a 0.89% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | NEM | |
|---|---|---|
Market Cap | $2.99B | $123.50B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $131.95 |
52-Week Low | $2.78 | $67.38 |
Enterprise Value | $2.58B | $120.09B |
Dividend Yield | — | 0.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
